BG104061A - Method for fat absorption reduction by an antilipase antibody - Google Patents

Method for fat absorption reduction by an antilipase antibody

Info

Publication number
BG104061A
BG104061A BG104061A BG10406100A BG104061A BG 104061 A BG104061 A BG 104061A BG 104061 A BG104061 A BG 104061A BG 10406100 A BG10406100 A BG 10406100A BG 104061 A BG104061 A BG 104061A
Authority
BG
Bulgaria
Prior art keywords
antilipase
antibody
fat absorption
absorption reduction
lipase
Prior art date
Application number
BG104061A
Other languages
Bulgarian (bg)
English (en)
Inventor
Julio Pimentel
Original Assignee
Ximed Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ximed Group Plc filed Critical Ximed Group Plc
Publication of BG104061A publication Critical patent/BG104061A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BG104061A 1997-07-07 2000-01-06 Method for fat absorption reduction by an antilipase antibody BG104061A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/888,202 US7344713B1 (en) 1997-07-07 1997-07-07 Decreased fat absorption with an anti-lipase antibody
PCT/GB1998/001998 WO1999002187A2 (en) 1997-07-07 1998-07-06 Decreased fat absorption with an anti-lipase antibody

Publications (1)

Publication Number Publication Date
BG104061A true BG104061A (en) 2000-11-30

Family

ID=25392734

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104061A BG104061A (en) 1997-07-07 2000-01-06 Method for fat absorption reduction by an antilipase antibody

Country Status (14)

Country Link
US (1) US7344713B1 (de)
EP (1) EP1001809B1 (de)
JP (1) JP2001525314A (de)
CN (1) CN1269728A (de)
AT (1) ATE260115T1 (de)
AU (1) AU8232698A (de)
BG (1) BG104061A (de)
BR (1) BR9815504A (de)
CA (1) CA2295735A1 (de)
DE (1) DE69821946D1 (de)
HU (1) HUP0002753A2 (de)
IL (1) IL133881A0 (de)
TR (1) TR200000002T2 (de)
WO (1) WO1999002187A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7618624B1 (en) * 1999-01-07 2009-11-17 Anitox Corporation Weight control using an anti-lipase antibody
US20040018197A1 (en) * 2002-04-26 2004-01-29 Promega Corporation Treatment for weight loss
GB2389362B (en) * 2002-06-05 2006-02-15 Walcom Animal Science Antibodies to adipose tissues
TW200507861A (en) * 2003-04-10 2005-03-01 Ghen Corp Antiobesity agent using hen-egg antibody against digestive enzyme
WO2008013455A1 (en) * 2006-07-27 2008-01-31 Lactive B.V. Means and methods for preventing elevated blood glucose levels in humans with animal antibodies produced in milk
WO2015083374A1 (ja) * 2013-12-02 2015-06-11 オーストリッチファーマ株式会社 消化酵素抗体およびそれを有する卵と卵を原料とする加工品および抗体を含む組成物と製造方法
US10538593B2 (en) 2013-12-02 2020-01-21 Ostrich Pharma Kk Method for manufacturing digestive enzyme antibody and egg having same, and for manufacturing processed product containing egg as ingredient thereof and composition including antibody
JP6872841B2 (ja) * 2014-04-28 2021-05-19 アサマ化成株式会社 脂肪低減組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
EP0225254B1 (de) * 1985-11-25 1994-03-16 Ghen Corporation Einen spezifischen Antikörper enthaltender Stoff aus Eiern, Verfahren zu dessen Herstellung und seine Anwendung
US5001225A (en) * 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
JPH0745520B2 (ja) * 1988-08-31 1995-05-17 国際試薬株式会社 モノクローナル抗体およびその使用法
US5753228A (en) * 1992-08-25 1998-05-19 Arizona Board Of Regents On Behalf Of The University Of Arizona Method of treating parasitosis by the enteral administration of hyperimmune hen egg yolk antibodies
US5585098A (en) * 1993-11-23 1996-12-17 Ovimmune, Inc. Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants

Also Published As

Publication number Publication date
BR9815504A (pt) 2000-11-28
JP2001525314A (ja) 2001-12-11
EP1001809B1 (de) 2004-02-25
TR200000002T2 (tr) 2000-09-21
ATE260115T1 (de) 2004-03-15
WO1999002187A2 (en) 1999-01-21
EP1001809A1 (de) 2000-05-24
CA2295735A1 (en) 1999-01-21
HUP0002753A2 (hu) 2000-12-28
CN1269728A (zh) 2000-10-11
WO1999002187A3 (en) 2001-06-07
DE69821946D1 (de) 2004-04-01
US7344713B1 (en) 2008-03-18
AU8232698A (en) 1999-02-08
IL133881A0 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
EP1142485A3 (de) Verfahren zur Verbesserung von der Löslichkeit von pflanzlichen Proteinen
EP0854917A4 (de) Transgene nicht-menschlicher tiere befaehigt zur produktion heterologer antikoerper
EP0942959A4 (de) Transgene nicht-menschliche tiere, die heterologe antikörper erzeugen können
ES2169219T3 (es) Aditivos alimenticios para animales que comprenden xilanasa.
EP0754225A4 (de) Heterologe antikörper produzierende transgene nicht-humane tiere
MY125875A (en) Method and food product for increasing muscle protein and reducing fat in animals
NZ331299A (en) Antibody variants with reduced affinity for a cell-surface antigen
DE60126104D1 (de) Ernährungszusammensetzung und verfahren zur verbesserung der absetzung von proteinen
NO2009012I1 (no) Humanisert anti-humant IL-6 reseptor monoklonalt antistoff
ZA912036B (en) Catalytic antibody components
EP1069185A4 (de) Humanisierter antikörper gegen den menschlichen gewebefaktor (tf) und verfahren für die konstruktion eines solchen humanisierten antikörpers.
RU2004132217A (ru) Способ улучшения всасывания витамина е в организме домашнего животного
PL344190A1 (en) Novel method for the production of anti-human antigen receptors and uses thereof
DK0649284T3 (da) Anvendelse af et mælkelignende produkt som fedterstatning til levnedsmidler
DK0444891T3 (da) Fødevarebestanddel med den funktion at forbedre serumlipid
CA2122863A1 (en) Animal Food Supplement Briquette
WO2001084949A3 (en) Protein and lipid sources for use in aquafeeds and animal feeds and a process for their preparation
WO1998018003A3 (de) Verfahren zum herkunftsnachweis von nutztieren sowie davon stammenden produkten
DE69821946D1 (de) Reduzierte fett-absorption durch anti-lipase antikörper
YU49406B (sh) Postupak za povećanje koncentracije konjugovane linolske kiseline u mleku i/ili masnom tkivu preživara
WO1999024835A3 (en) An immunoassay for procollagen-iii-c-terminal propeptide
DE3477726D1 (en) Composition suitable for imparting butter and/or animal notes, and method of making same
KR950030828A (ko) 가축용 사료 조성물
GR1002419B (el) Μεθοδος επεξεργασιας φυτικων προιοντων με βαση την ελατη για παραγωγη εκχυλισματος με βιολογικες δρασεις και χρηση του για τη θεραπεια νοσων στον ανθρωπο και στα ζωα.
FR2361072A1 (fr) Ingredient d'aliment pour animaux